CHIMERIX INC. - COMMON STOCK

Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update

03 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023

27 июл 2023 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer

27 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire

Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

31 май 2023 16:01:00 Источник Nasdaq GlobeNewswire

Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House

25 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update

04 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023

27 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting

18 апр 2023 16:01:00 Источник Nasdaq GlobeNewswire

Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update

02 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference

28 фев 2023 16:05:01 Источник Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023

23 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference

05 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update

08 дек 2022 17:00:00 Источник Nasdaq GlobeNewswire

Chimerix Responds to Rubric Capital Management

10 ноя 2022 16:30:00 Источник Nasdaq GlobeNewswire

Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update

03 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022

27 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire

Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions

26 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire

Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox

29 авг 2022 10:45:00 Источник Nasdaq GlobeNewswire

Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update

08 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire